RTÉ Executive Board

EQS-News: Change in the ANDRITZ Executive Board

Retrieved on: 
Thursday, December 14, 2023
RTÉ Executive Board, Schuler Group, Metal, Security (finance)

ANDRITZ and Domenico Iacovelli have mutually agreed upon amicable terms for his resignation effective December 31, 2023.

Key Points: 
  • ANDRITZ and Domenico Iacovelli have mutually agreed upon amicable terms for his resignation effective December 31, 2023.
  • He has played a key role on the Executive Board, overseeing Metals business area.
  • I wish him all the best in the next phase of his career,” says Joachim Schönbeck, President and CEO of ANDRITZ GROUP.
  • Effective January 1, 2024, Joachim Schönbeck will assume the Executive Board responsibilities previously held by Mr. Iacovelli.

EQS-News: Changes in the Supervisory Board of BAUER AG

Retrieved on: 
Thursday, December 14, 2023
Dark Ages, Supervisory board, RTÉ Executive Board, Property management

Schrobenhausen, Germany – There have recently been changes to the Supervisory Board of BAUER AG.

Key Points: 
  • Schrobenhausen, Germany – There have recently been changes to the Supervisory Board of BAUER AG.
  • With effect from November 2, Mr. Alfons Doblinger joined the Supervisory Board of BAUER AG as a shareholder representative.
  • In addition, there will be a change at the top of the Supervisory Board of BAUER AG.
  • On behalf of all employees of the BAUER Group, the Executive Board and the members of the Supervisory Board would like to thank Prof. Thomas Bauer for his life's work, his decades of commitment in the top management of the company and most recently as Chairman of the Supervisory Board.

EQS-News: Eckert & Ziegler with Significant Sales Growth in the First Nine Months of 2023

Retrieved on: 
Thursday, December 14, 2023
SDAX, Nuclear medicine, Growth, ISIN, Medicine, RTÉ Executive Board

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, SDAX) achieved sales of € 183.9 million in the first nine months of 2023 (previous year: € 165.8 million) and consolidated net income of € 20.3 million (previous year: € 21.7 million).

Key Points: 
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, SDAX) achieved sales of € 183.9 million in the first nine months of 2023 (previous year: € 165.8 million) and consolidated net income of € 20.3 million (previous year: € 21.7 million).
  • Adjusted for currency losses of € 3.3 million, the nine-month result was around € 2 million higher than the previous year's figure.
  • In the Medical segment, sales of € 82.8 million were around € 17.6 million or 27% higher than in the previous year.
  • The Executive Board continues to expect sales of around € 230 million and net income of around € 25 million.

EQS-News: Vitesco Technologies publishes Reasoned Statement on the Public Tender Offer and enters into Business Combination Agreement with Schaeffler

Retrieved on: 
Thursday, December 14, 2023
Employment, Remuneration, Growth, Knowledge, Supervisory board, Vitesco Technologies, Drivetrain, BCA, Chassis, Communication, Perella Weinberg Partners, Business analyst, Herzogenaurach, RTÉ Executive Board, J. P. Morgan, Lazard, Security (finance), Management, Audit, Financial services, Schaeffler Group

In addition, Schaeffler today published an updated tender offer, which includes an increase of the offer price to EUR 94 per Vitesco Technologies share.

Key Points: 
  • In addition, Schaeffler today published an updated tender offer, which includes an increase of the offer price to EUR 94 per Vitesco Technologies share.
  • The allocation of the remaining divisional headquarters will be discussed in more detail between Vitesco Technologies and Schaeffler.
  • Vitesco Technologies and Schaeffler are aware of the importance of the Vitesco Technologies locations for the combined company.
  • Vitesco Technologies will manage its business independently both until the completion of the tender offer and thereafter until a possible merger.

EQS-News: GESCO SE publishes 9-month report 2023

Retrieved on: 
Thursday, December 14, 2023
Steel, RTÉ Executive Board, ISIN, Paper, Consumer, Construction, EBIT, Investment

Prime Standard-listed GESCO SE (ISIN DE000A1K0201), an industrial group of medium-sized market and technology leaders, today published its 9-month report 2023.

Key Points: 
  • Prime Standard-listed GESCO SE (ISIN DE000A1K0201), an industrial group of medium-sized market and technology leaders, today published its 9-month report 2023.
  • The weak economic situation in Germany has increasingly clouded GESCO Group's business environment in recent months, dashing hopes of an upturn in the second half of the year.
  • In light of this and other current information on the development, non-cash impairments of the investments are unavoidable.
  • These necessary impairments and the slowdown in business momentum prompted the Executive Board to adjust the forecast corridor for the current 2023 financial year on 3 November.

Ørsted implements changes to executive management

Retrieved on: 
Wednesday, December 13, 2023
EPC, Wind, CFO, Senior, RTÉ Executive Board, Shell, Management, Region (Europe), Finance

By mutual agreement, two members of executive management are stepping down and leaving Ørsted with immediate effect: Daniel Lerup, Chief Financial Officer (CFO), and Richard Hunter, Chief Operating Officer (COO).

Key Points: 
  • By mutual agreement, two members of executive management are stepping down and leaving Ørsted with immediate effect: Daniel Lerup, Chief Financial Officer (CFO), and Richard Hunter, Chief Operating Officer (COO).
  • Mads Nipper, Group President and CEO of Ørsted, says:
    “Ørsted, along with the rest of the industry, is experiencing a challenging and volatile business environment.
  • I would like to thank both Daniel Lerup and Richard Hunter for their contributions to Ørsted.
  • Currently, Rasmus Errboe is CEO of Region Europe and Executive Vice President at Ørsted and has been with the company since 2012 in different management positions, including as CFO for Ørsted’s offshore wind business.

EQS-News: IMMOFINANZ AG: Change on the Supervisory Board

Retrieved on: 
Wednesday, December 13, 2023
VIVO, Supervisory board, ATX, RTÉ Executive Board, Adriatic Sea, Hungary, Austria, Slovakia, Czech Republic

Gayatri Narayan has informed IMMOFINANZ AG that she will resign from the Supervisory Board as of 31 December 2023 for personal reasons.

Key Points: 
  • Gayatri Narayan has informed IMMOFINANZ AG that she will resign from the Supervisory Board as of 31 December 2023 for personal reasons.
  • “On behalf of the Supervisory Board and the Executive Board, I would like to thank Gayatri Narayan for her contribution and her diligent work on the IMMOFINANZ Supervisory Board“, commented Miroslava Greštiaková, Chairwoman of the IMMOFINANZ Supervisory Board.
  • The core business covers the management and development of properties, whereby IMMOFINANZ relies on its established real estate brands – STOP SHOP (retail), VIVO!
  • IMMOFINANZ Group holds roughly 500 properties with a combined value of approximately EUR 7.8 billion.

EQS-News: Heidelberg Pharma AG: Heidelberg Pharma Announces Changes to the Executive Management Board

Retrieved on: 
Wednesday, December 13, 2023
HPHA, Teaching, Research, Chemistry, Research and development, FSE, Supervisory board, ADC, RTÉ Executive Board, Pharmaceutical industry

His successor will be Prof. Dr. Andreas Pahl, Chief Scientific Officer

Key Points: 
  • His successor will be Prof. Dr. Andreas Pahl, Chief Scientific Officer
    Ladenburg, Germany, 29 November 2023 – Heidelberg Pharma AG (FSE: HPHA) today announced that Dr. Jan Schmidt-Brand, Chief Executive Officer (CEO) of Heidelberg Pharma AG and Managing Director of the subsidiary Heidelberg Pharma Research GmbH, is planning to retire at the beginning of February 2024 and step down from his positions.
  • Prof. Pahl has been Head of Research & Development at Heidelberg Pharma since 2012 and has been a member of the Executive Board since 2016.
  • Dr. Schmidt-Brand has been with Heidelberg Pharma since 2001, first as Managing Director of the subsidiary Heidelberg Pharma Research GmbH and since 2012 as a member of the Management Board of Heidelberg Pharma AG.
  • Prof. Christof Hettich, Chairman of the Supervisory Board of Heidelberg Pharma AG, commented: "On behalf of the Supervisory Board, I would like to sincerely thank Dr. Schmidt-Brand for his many years of service on the Executive Management Board of Heidelberg Pharma AG.

EQS-News: Top 40 under 40: FUCHS CFO Isabelle Adelt honored by Capital magazine

Retrieved on: 
Tuesday, December 12, 2023
Ernst & Young, CFO, Capital, Female, AI, Science, Woman, Digital, RTÉ Executive Board, MDAX, Management

She has now been recognized by the business magazine Capital as an important talent shaping Germany and voted one of the "Top 40 under 40" in the management category.

Key Points: 
  • She has now been recognized by the business magazine Capital as an important talent shaping Germany and voted one of the "Top 40 under 40" in the management category.
  • The business magazine Capital has now honored her for this and included her in the "Top 40 under 40" managers.
  • "I am proud that my commitment has been recognized by the renowned business experts at Capital magazine," says a delighted Isabelle Adelt.
  • In addition to traditional CFO tasks, Isabelle Adelt is also responsible for digitalization, legal, compliance and investor relations.

EQS-News: CANCOM SE: Supervisory Board of the CANCOM Group reorganized

Retrieved on: 
Tuesday, December 12, 2023
CANCOM, Supervisory board, RTÉ Executive Board, Annual general meeting, DACH, IPO, SE, Property management

Munich, Germany, 12 December 2023 – At its meeting today, the Supervisory Board of CANCOM SE reorganised the responsibilities on the Board.

Key Points: 
  • Munich, Germany, 12 December 2023 – At its meeting today, the Supervisory Board of CANCOM SE reorganised the responsibilities on the Board.
  • Klaus Weinmann, who was appointed to the Supervisory Board by court order on 25 October 2023, was elected Chairman of the Supervisory Board at today's meeting.
  • The Executive Board and Supervisory Board would like to thank Dr. Koniarski in particular for his trustworthy and constructive work on the Supervisory Board of CANCOM SE over the past ten years.
  • In addition, the Supervisory Board and the Executive Board wish the new Chairman of the Supervisory Board, Klaus Weinmann, a good start and thank Stefan Kober for his work as Chairman of the Supervisory Board.